Tuesday, September 30, 2014
Inquirer Daily News

AmerisourceBergen revenue down 1.9 percent for quarter, diluted EPS up 8 percent

Valley Forge-based pharmaceutical wholesaler AmerisourceBergen reported Thursday that it had a 1.9 percent drop in revenue for the quarter, but an 8 percent increase in the diluted earnings per share.

AmerisourceBergen revenue down 1.9 percent for quarter, diluted EPS up 8 percent

Valley Forge-based pharmaceutical wholesaler AmerisourceBergen reported Thursday that it had a 1.9 percent drop in revenue for the quarter, but an 8 percent increase in the diluted earnings per share.

AmerisourceBergen's fiscal year ends in September, so the company just completed its third quarter.

The company's report indicated there was a 1.7 percent drop in net income from the same period in 2011.

The highlights from the company press release are below:

VALLEY FORGE, PA, July 26, 2012 - AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year third quarter ended June 30, 2012, diluted earnings per share were $0.71, an 8 percent increase over the prior year quarter. Revenue in the quarter was $19.8 billion, down 1.9 percent. The Company also narrowed the range of its expectations for the full fiscal year 2012 diluted earnings per share to $2.80 to $2.84 from its previous range of $2.74 to $2.84. All the results are presented in accordance with U.S. generally accepted accounting principles (GAAP).

Fiscal Third Quarter Highlights

• Revenue of $19.8 billion, down 1.9 percent.

• Diluted earnings per share of $0.71, a 7.6 percent increase.

• Gross margin of 3.49 percent, up 25 basis points.

• Operating margin of 1.59 percent, up 2 basis points.

• Share repurchases of $186 million.

Fiscal First Nine Months Highlights

• Revenue of $60.2 billion, up 0.7 percent.

• Diluted earnings per share of $2.13, a 6.5 percent increase.

• Gross margin of 3.28 percent, a 7 basis point increase.

• Operating margin of 1.61 percent, a 1 basis point increase.

• Cash flow from operations of $760 million.

• Share repurchases of $514 million.

 

 

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Business Videos:
Also on Philly.com:
Stay Connected